Orange Book product · Brand (NDA)

EVOTAZ

ATAZANAVIR SULFATE; COBICISTAT

Brand (NDA)NDA 206353RX BRISTOL

Jan 29, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Jan 29, 2015
11 yr 7 mo ago
Today
Patent 8148374 expires
Listed drug substance patent expiration.
Sep 03, 2029
in 3 yr 3 mo
Patent 10039718 expires
Listed drug product patent expiration.
Oct 06, 2032
in 6 yr 5 mo

Active ingredient

ATAZANAVIR SULFATE; COBICISTAT

Strength

EQ 300MG BASE;150MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 206353

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8148374	Sep 03, 2029	in 3 yr 3 mo	SubstanceProductU-1279
10039718	Oct 06, 2032	in 6 yr 5 mo	Product